Concepedia

H. W. Dalrymple

HW

Statistics

Publications

8

Citations

499

H-Index

8

Active since

1968

Affiliations

Pfizer (United Kingdom)(Current)

H. W. Dalrymple is an author at Pfizer (United Kingdom) specializing in drug discovery, medicine, and physiology.

Top concepts

Publications per year

1968–1993

8

Publications

8

UK-68,798: a novel, potent and highly selective class III antiarrhythmic agent which blocks potassium channels in cardiac cells.

Michael Gwilt, John Arrowsmith, Kenneth J. Blackburn et al. · Journal of Pharmacology and Experimental Therapeutics · 1990 · 188 citations

Dofetilide, A Novel Class III Antiarrhythmic Agent

Henrik Rasmussen, Michael J. Allen, Kenneth J. Blackburn et al. · Journal of Cardiovascular Pharmacology · 1992 · 87 citations

, , +15

Fertility and nuptiality changes in Spain from the late 18th to the early 20th century

Massimo Livi Bacci, Alicia Pardo, Alicia Pardo et al. · Population Studies · 1968 · 68 citations

, , +23

Dofetilide, A Novel Class III Antiarrhythmic Agent

H. S. Rasmussen, Michael J. Allen, Kenneth J. Blackburn et al. · Journal of Cardiovascular Pharmacology · 1992 · 59 citations

, , +16

Electrophysiologic Properties of UK-66,914, a Novel Class III Antiarrhythmic Agent

Michael Gwilt, H. W. Dalrymple, Roger A. Burges et al. · Journal of Cardiovascular Pharmacology · 1991 · 38 citations

, , +17

1–5 of 8